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224 ABSTRACT
25 Assisted reproduction technologies (ART) are becoming increasingly common. Therefore, 
26 how these procedures influence gene regulation and feto-placental development are 
27 important to explore. Here, we assess the effects of blastocyst transfer on mouse placental 
28 growth and transcriptome. C57Bl/6 blastocysts were transferred into uteri of B6D2F1 
29 pseudopregnant females and dissected at embryonic day 10.5 for analysis. Compared to 
30 non-transferred controls, placentas from transferred conceptuses weighed less even 
31 though the embryos were larger on average. This suggested a compensatory increase in 
32 placental efficiency. RNA-sequencing of whole male placentas revealed 543 differentially 
33 expressed genes (DEGs) after blastocyst transfer: 188 and 355 genes were down-
34 regulated and up-regulated, respectively. DEGs were independently validated in male and 
35 female placentas. Bioinformatic analyses revealed that DEGs represented expression in 
36 all major placental cell types and included genes that are critical for placenta development 
37 and/or function. Furthermore, the direction of transcriptional change in response to 
38 blastocyst transfer implied an adaptive response to improve placental function to maintain 
39 fetal growth. Our analysis revealed that CpG methylation at regulatory regions of two 
40 DEGs was unchanged in female transferred placentas and that DEGs had fewer gene-
41 associated CpG islands (within ~20 kb region) compared to the larger genome. These 
42 data suggested that altered methylation at proximal promoter regions might not lead to 
43 transcriptional disruption in transferred placentas. Genomic clustering of some DEGs 
44 warrants further investigation of long-range, cis-acting epigenetic mechanisms including 
45 histone modifications together with DNA methylation. We conclude that embryo transfer, a 
46 protocol required for ART, significantly impacts the placental transcriptome and growth.
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347 INTRODUCTION
48 More than seven million babies worldwide have been born using some form of assisted 
49 reproduction technology (ART) largely as a treatment approach to infertility (European 
50 Society of Human Reproduction and Embryology (ESHRE), 2018 February 18. ART Fact 
51 Sheet. Retrieved from https://www.eshre.eu/. Grimbergen, Belgium). ART includes a range 
52 of procedures with varying degrees of invasiveness (e.g., superovulation, in vitro 
53 fertilisation (IVF), intracytoplasmic sperm injection, embryo culture, embryo biopsy, gamete 
54 and embryo vitrification, and blastocyst transfer). While ART is generally safe, growing 
55 evidence suggests that individuals born using these technologies are at an increased risk 
56 of intrauterine growth restriction, perinatal complications (Quinn & Fujimoto 2016), and/or 
57 developing cardiovascular disease later in life (Tararbit et al. 2013, Valenzuela-Alcaraz et 
58 al. 2013, Liu et al. 2015, Guo et al. 2017). Since optimal placental function is required for 
59 normal fetal growth and development, it is predicted that placenta pathologies are 
60 responsible for some of the adverse pregnancy outcomes associated with ART (Delle 
61 Piane et al. 2010, Thomopoulos et al. 2013, Choux et al. 2015). Indeed, ART pregnancies 
62 were overrepresented in the highest quartile of placental weight and underrepresented in 
63 the highest quartile of birthweight (Haavaldsen et al. 2012). 
64 To explore the effects of ART on placental structure and function, animal models 
65 have been utilised. Similar to humans, the mouse placentation site is composed of three 
66 major layers: the outer maternal layer, which includes decidual cells of the uterus, 
67 maternal immune cells, and the maternal vasculature that brings blood to and from the 
68 implantation site; the metabolic ‘junctional’ region, containing many endocrine cells and 
69 which attaches the placenta to the uterus through the invasion of trophoblast cells; and an 
70 inner layer composed of highly branched villi required for nutrient, gas, and waste 
71 exchange between maternal and fetal circulations (Watson & Cross 2005). Defects in 
72 placenta development and/or function have repercussions for fetal growth and health 
Page 3 of 53 Accepted Manuscript published as REP-19-0293.R2. Accepted for publication: 18-Nov-2019
Copyright © 2019 Society of Reproduction and FertilityDownloaded from Bioscientifica.com at 11/29/2019 03:31:29PM
via University of Cambridge
473 (Watson & Cross 2005, Perez-Garcia et al. 2018). IVF and/or superovulation in mice are 
74 associated with large placentas with reduced vascular density and altered nutrient 
75 transport at late gestation to produce normal-sized or growth-restricted fetuses (Delle 
76 Piane et al. 2010, Bloise et al. 2012, Weinerman et al. 2017). Indeed, sub-optimally 
77 formed placentas might undergo counter-balancing mechanisms leading to adaptive 
78 responses (Choux et al. 2015). How and when this dialogue occurs is unclear.
79 The mechanism through which ART influences the formation and function of the 
80 maternal-fetal interface is not well understood. The vast majority of studies have focused 
81 on CpG methylation of imprinted genomic loci (Khosla et al. 2001, Mann et al. 2004, 
82 Fortier et al. 2008, Rivera et al. 2008, de Waal et al. 2014, Fauque et al. 2010, Wang et al. 
83 2010, Bloise et al. 2012). Genomic imprinting is an epigenetic phenomenon in mammals 
84 whereby a small number of genes are expressed in a parent-of-origin-specific manner, a 
85 process that is regulated by DNA methylation. Many imprinted genes are expressed in the 
86 placenta and are important for its development and function (Tunster et al. 2013). Directed 
87 analysis of imprinted regions can act as a convenient read-out of functional DNA 
88 methylation changes across the genome (Padmanabhan et al. 2013). Therefore, studies 
89 showing altered DNA methylation at imprinted loci after ART hypothesize that these 
90 technologies might influence the establishment of DNA methylation genome-wide with 
91 consequences for placental cell differentiation (Choux et al. 2015). Dysregulation of other 
92 epigenetic mechanisms (e.g., histone modifications, non-coding RNA expression) are 
93 largely unstudied in the context of ART. 
94 One procedure that all ART have in common is the transfer of the blastocyst into 
95 the uterus of a recipient female. While many ART studies in mice have taken into account 
96 the potential effects of blastocyst transfer (Kholsa et al. 2001, Delle Piane et al. 2010, 
97 Fauque et al. 2010, Bloise et al. 2012), the impact of this procedure alone on placentation 
98 site growth and transcription is not well understood. Here, we show that blastocyst transfer 
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599 in mice has a stark impact on transcriptional regulation and likely influences placental 
100 efficiency even as the placenta matures. Furthermore, our genome-wide approach 
101 enabled us to determine that changes in DNA methylation at proximal promoter regions 
102 may not cause transcriptional disruption. Therefore, a long-range study of cis-acting 
103 epigenetic mechanisms in addition to DNA methylation is required.    
104
105
106
107 MATERIALS AND METHODS
108 Mice 
109 C57Bl/6 conceptuses were generated by natural mating of C57Bl/6 mice at 7-10 weeks of 
110 age. No hormones were used. [C57Bl/6 x DBA/2] F1 hybrid (B6D2F1) female mice were 
111 mated at 7-10 weeks of age with vasectomized C57Bl/6 males to generate a 
112 pseudopregnant state. B6D2F1 mice have 50% genetic similarity to C57Bl/6 mice and 
113 were used because C57Bl/6 females are notoriously poor recipients for blastocyst transfer. 
114 A broad range of genetic backgrounds has been used for donor and recipient mice across 
115 ART studies (Mann et al. 2004, Fortier et al. 2008, Piane et al. 2010, Wang et al. 2010, 
116 Chen et al. 2015), including hybrid recipient females as in our study (Kholsa et al. 2001, 
117 Fauque et al. 2010, Bloise et al. 2012). C57Bl/6 conceptuses that were derived by natural 
118 mating and did not undergo the transfer process were used as controls. Noon of the day 
119 that the copulatory plug was detected was considered embryonic (E) day 0.5. Mice were 
120 euthanized via cervical dislocation. All experiments were performed in accordance with the 
121 Canadian Council on Animal Care and the University of Calgary Committee on Animal 
122 Care (protocol number M06109). This research was also regulated under the Animal 
123 (Scientific Procedures) Act 1986 Amendment Regulations 2012 following ethical review by 
124 the University of Cambridge Animal Welfare and Ethical Review Body. 
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126 Blastocyst transfers
127 Conceptuses from the blastocyst transfer experiment were generated as previously 
128 described (Padmanabhan et al. 2013). Briefly, using M2 media (Sigma-Aldrich, Gillingham, 
129 UK), embryos were flushed at E3.25 from the oviducts and uteri of C57Bl/6 females. 
130 Embryos were cultured in KSOM media (Millipore, Etobicoke, Canada) microdrops 
131 covered in mineral oil (Millipore) at 37°C for no more than 30 minutes. This unavoidable 
132 culture period allowed for the surgical preparation of the recipient female. Embryos were 
133 transferred by injection into the oviducts of pseudopregnant B6D2F1 recipients 2.5 days 
134 after mating them with vasectomized C57Bl/6 males. Litters were never pooled. 
135
136 Dissections and phenotyping
137 All conceptuses were dissected at E10.5. For transferred litters, the timing of dissection 
138 corresponded to the staging of the recipient female (Ueda et al. 2003). Implantation sites 
139 were dissected away from the uterine myometrium in cold 1x phosphate buffered saline. 
140 Embryos and placentas were rigorously scored for gross phenotypes (see below and 
141 Padmanabhan et al. 2013), photographed, weighed, and snap frozen in liquid nitrogen for 
142 storage at -80°C. Similar to other ART studies on mouse placenta (Fauque et al. 2010, 
143 Wang et al. 2010, Fortier et al. 2008, Rivera et al. 2008, Bloise et al. 2012), whole 
144 placentas including the mesometrial decidua were assessed. Retaining the decidua is 
145 important for sample consistency since reliably removing the decidua without influencing 
146 parietal trophoblast giant cell (TGC) numbers is difficult. It also contains invading 
147 trophoblast cells (Simmons et al. 2008) that are important to assess.
148 For phenotype scoring, defective embryo growth was determined by assessing 
149 crown-rump length and somite pairs. Crown-rump lengths that were greater or less than 
150 two standard deviations from the mean crown-rump length of C57Bl/6 controls were 
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7151 distinguished as growth enhancement or restriction, respectively. Somite staging was 
152 determined according to e-Mouse Atlas Project (http://www.emouseatlas.org): 30-39 
153 somite pairs were considered the normal range for E10.5 and somite pairs <30 indicated 
154 developmental delay. Embryos were also assessed for the appearance of hemorrhage, 
155 resorptions, twinning, and congenital malformations including defective neural tube 
156 closure, abnormal heart loop directionality, and/or presence of pericardial edema or heart 
157 enlargement. Placentas were grossly scrutinized for the presence and orientation of 
158 chorioallantoic attachment and hemorrhage. Sex of conceptuses was determined by 
159 polymerase chain reaction (PCR) genotyping of yolk sac DNA using reported methods 
160 (Chuma & Nakatsuji 2001, Tunster 2017). Images were obtained using a Zeiss SteREO 
161 Discovery V8 microscope with an AxioCam MRc5 camera and AxioVision 4.7.2 software 
162 (Carl Zeiss Ltd, Cambridge, UK).
163
164 RNA and DNA extraction
165 Whole placentas were homogenized using lysing matrix D beads (MP Biomedicals, 
166 Carlsbad, USA). For quantitative reverse transcription-PCR (qRT-PCR) analysis, total 
167 RNA was extracted using TRIzol reagent (Sigma-Aldrich) according to the manufacturer’s 
168 instructions. For methylation analysis, DNA and RNA were extracted using the AllPrep 
169 DNA/RNA kit (QIAGEN, Manchester, UK). All RNA extracts were treated with DNAse I 
170 (Thermo Scientific, Waltham, USA).
171
172 Transcriptome analysis
173 RNA libraries were prepared from whole placentas of non-transferred and transferred 
174 C57Bl/6 conceptuses at E10.5. Four male placentas taken from 3-4 litters were assessed 
175 per experimental group. Placentas chosen for analysis were associated with 
176 phenotypically normal embryos (i.e., the embryos displayed normal crown-rump lengths 
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8177 and somite pair counts, and were absent of congenital malformations). Library preparation 
178 and sequencing was performed by Cambridge Genomic Services, Department of 
179 Pathology, University of Cambridge. The concentration and purity of RNA was determined 
180 by a SpectroStar spectrophotometer (BMG LABTECH, Aylesbury, UK) and an Agilent 
181 Tapestation Bioanalyzer (Aligent Technologies LDA UK Ltd, Stockport, UK) determined 
182 RNA integrity. Libraries were prepared using 200 ng of total RNA and TruSeq stranded 
183 mRNA Library Preparation kit (Illumina, Chesterford, UK). A unique index sequence was 
184 added to each RNA library to allow for multiplex sequencing. Libraries were pooled and 
185 sequenced on the Illumina NextSeq500 platform with 75-base-pair single-end reads. 
186 Sequencing was performed in duplicate to provide >18 million reads per sample. To 
187 monitor sequencing quality control, 1% PhiX Control (Illumina) spike-in was used. Quality 
188 control of Fastq files was performed using FastQC and fastq_screen. Sequences were 
189 trimmed with Trim Galore! and aligned to GRCm38 mouse genome using STAR aligner. 
190 Alignments were processed using custom ClusterFlow (v0.5dev) pipelines and assessed 
191 using MultiQC (0.9.dev0). Gene quantification was determined with HTSeq-Counts 
192 (v0.6.1p1). Additional quality control was performed with rRNA and mtRNA counts script, 
193 feature counts (v 1.5.0-p2) and qualimap (v2.2). Differential gene expression was 
194 performed with DESeq2 package (v1.22.2, R v3.5.2). Read counts were normalised on the 
195 estimated size factors. Principle component analysis was performed on the rlog 
196 transformed count data for the top 5,000 most variable genes. Heatmaps were generated 
197 with ‘ComplexHeatmap' R package (v 1.20.0). Karyoplots were generated with 
198 karyoploteR (v1.8.8). 
199
200 Data availability
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9201 The RNA-sequencing data is accessible through ArrayExpress EMBL-EBI accession 
202 number E-MTAB-8036. All code to reproduce the bioinformatics analysis are freely 
203 available from https://github.com/CTR-BFX/2019-Menelaou-Watson.
204
205 Quantitative reverse transcription-PCR (qRT-PCR)
206 Primers were designed using NCBI Primer-BLAST software (Ye et al. 2012). For primer 
207 sequences, refer to Supplementary table 1. Reverse transcription reactions were 
208 performed with the RevertAid H Minus reverse transcriptase (Thermo Scientific) and 
209 random hexamer primers (Thermo Scientific) using 1 μg of total RNA according to 
210 manufacturer’s instructions. PCR amplification was performed using MESA SYBR Green 
211 qPCR MasterMix Plus (Eurogentec, Liege, Belgium) on a DNA Engine Opticon2 
212 thermocycler (BioRad, Hercules, USA). Transcript levels were normalised to Polr2a RNA 
213 and analysed using the comparative Ct method. cDNA levels in C57Bl/6 control placentas 
214 were normalised to 1. For qRT-PCR validation of the RNA-seq experiment, 4-7 whole male 
215 or female placentas were analysed per experimental group from 2-4 litters, and were 
216 independent of those assessed by RNA-seq. Experiments were conducted in technical 
217 triplicates.
218
219 Bisulfite pyrosequencing
220 Genomic DNA was bisulphite converted using the Imprint DNA Modification Kit (Sigma-
221 Aldrich) using the one-step modification procedure. Pyrosequencing assays were 
222 designed using PyroMark Assay Design SW 2.0 software (QIAGEN). For primer 
223 sequences, refer to Supplementary table 1. PCR was performed in triplicate using 
224 HotStarTaq DNA polymerase (QIAGEN) and 5 ng of bisulphite-converted DNA with the 
225 following PCR conditions: 95°C for 5 minutes followed by 95°C for 30 seconds, 56°C for 30 
226 seconds and 72°C for 55 seconds for 40 cycles, then 72°C for 5 minutes. PCR products 
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227 were bound to Streptavidin Sepharose High Performance beads (GE Healthcare, Chicago, 
228 USA) and purified by sequential washing in 70% ethanol, 0.4 mol/L NaOH and 10 mmol/L 
229 Tris-acetate (pH 7.6) using a Pyromark Q96 Vacuum Prep Workstation (QIAGEN). The 
230 purified product was mixed with the pyrosequencing primer in annealing buffer (20 mmol/L 
231 Tris-acetate pH 7.6, 2 mmol/L magnesium acetate), incubated at 85°C for 4 minutes then 
232 at room temperature for 4 minutes. Pyrosequencing was conducted using PyroMark Gold 
233 reagents (QIAGEN) on a PyroMark MD pyrosequencer (QIAGEN). Analysis of methylation 
234 status was performed using Pyro Q-CpG 1.0.9 software (Biotage, Hengoed, UK). The 
235 mean CpG methylation was calculated using five whole female placentas from 3-4 litters 
236 and at least two technical replicates per experimental group. 
237
238 Statistical Analysis
239 Statistical analyses were performed using GraphPad Prism 6 software (La Jolla, USA). 
240 Parametric data (e.g., litter sizes, crown-rump lengths, placenta weights, weight ratios) 
241 were analysed using t tests. Relative risks were determined to compare males and 
242 females of each phenotypic group, and p-values were calculated using Fisher’s exact test. 
243 For the RNA-sequencing data, the nbinomTest was used in R to calculate the p-value and 
244 p-adjusted value of differentially expressed genes (DEGs). For mRNA expression, data 
245 was analysed using Mann-Whitney tests or t tests with Welch correction where 
246 appropriate. Pyrosequencing data was analysed using t tests when primers spanned a 
247 single CpG site and two-way ANOVA with Sidak’s multiple comparisons test when primers 
248 spanned two or more CpG sites. Frequency of CpG repeats was determined using 
249 Fisher’s exact test. P<0.05 was considered significant. 
250
251 Software and online resources
252 Graphs were generated using GraphPad Prism 6 software. DEGs were subject to 
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253 enrichment analysis using Enrichr (http://amp.pharm.mssm.edu/Enrichr/) (Chen et al. 
254 2013a, Kuleshov et al. 2016). Placental gene expression was determined using the Mouse 
255 Encode Project (http://www.mouseencode.org/) (Yue et al. 2014) and Mouse Cell Atlas 
256 (http://bis.zju.edu.cn/MCA/) (Han et al. 2018). Some phenotype data was obtained from 
257 Deciphering the Mechanisms of Developmental Disorders database (https://dmdd.org.uk), 
258 which is funded by the Wellcome Trust (www.wellcome.ac.uk) with support from the 
259 Francis Crick Institute (www.crick.ac.uk) and is licensed under a Creative Commons 
260 Attribution license (https://creativecommons.org/licenses/by/4.0/legalcode). CpG islands 
261 were identified with the University of California, Santa Cruz (UCSC) Mouse Genome 
262 Browser (http://genome.ucsc.edu/) using NCBI37/mm9 mouse genome assembly of the 
263 C57Bl/6 genome (Haeussler et al. 2019). CpG island tracks were defined as a stretch of 
264 DNA between 200-1300 bp with a GC content >50% and a ratio of observed:expected 
265 CpG dinucleotides >0.6. The enhancer-promoter units (EPUs) were generated according 
266 to previously published data (Shen et al. 2012). For this analysis, UCSC Mouse Genome 
267 Browser (http://genome.ucsc.edu/) using NCBI37/mm9 mouse genome assembly of the 
268 C57Bl/6 genome (Haeussler et al. 2019) was used to determine CpG island tracks and to 
269 analyse C57Bl/6 placenta histone modification peaks from the ENCODE ChIP-seq data 
270 set (GEO accession: GSM1000133, GSM1000134) (ENCODE Project Consortium 2012, 
271 Yue et al. 2014). The NCBI37/mm9 coordinates were lifted over to GRCm38/mm10 using 
272 LiftOver tool from UCSC. To generate an intersect between DEGs (log2fc1) and EPUs, 
273 bedtools2 (v2.26.0) software was used. Random gene lists were generated using Random 
274 Gene Set Generator (www.molbiotools.com). 
275
276 RESULTS
277 Blastocyst transfer potentially leads to increased placental efficiency at E10.5
278 To better understand how blastocyst transfer affects fetoplacental development, we mated 
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279 C57Bl/6 female mice (N=10) without superovulation to C57Bl/6 males (N=10). Pre-
280 implantation embryos were flushed at E3.25 from oviducts and uteri of donor females and 
281 transferred into oviducts of pseudopregnant B6D2F1 females. Transferred blastocysts 
282 were allowed to implant and were dissected at E10.5 (staged according to recipient 
283 females (Ueda et al. 2003)) for phenotyping. C57Bl/6 control conceptuses were derived 
284 from natural matings, did not undergo the blastocyst transfer procedure, and were 
285 dissected at E10.5 for similar analyses. 
286 Prior to transfer, litter sizes at E3.25 ranged between 7-10 embryos and included 
287 compact morula- and blastocyst-staged embryos (Table 1). Two litters contained at least 
288 one embryo with an abnormal appearance (Table 1). However, all embryos were 
289 transferred regardless of appearance. Ten pseudopregnant B6D2F1 females received 
290 embryos but only eight were pregnant at E10.5 (80% efficiency). The average implantation 
291 rate was 47.2% when all transferred litters were considered and 58.9% when only 
292 considering transfers that resulted in pregnancy. Thus, litter sizes in the blastocyst transfer 
293 group were significantly smaller (5.4 ± 0.5 implantation sites/litter; p<0.001) than control 
294 litters (9.5 ± 0.4 implantation sites/litter) (Table 2). No congenital malformations or gross 
295 placental phenotypes were apparent in control or transferred conceptuses at E10.5 (see 
296 methods, Table 2). However, one litter in the transfer group was developmentally delayed 
297 since the number of somite pairs in these embryos ranged between 16-22 pairs (Fig. 1A) 
298 instead of the expected 30-40 somite pairs. At E10.5, 20.9% of the transferred 
299 conceptuses were resorbed compared to only 5.3% of controls (Table 2). Although not 
300 statistically significant (p=0.200), this result suggested that blastocyst transfer might lead 
301 to increased post-implantation lethality before E10.5. A larger data set is required to 
302 explore this finding further.  
303 Overall, male and female conceptuses were present in a 1:1 ratio at E10.5 in both 
304 control and transferred groups (Table 2) indicating that sex was not a selective factor on 
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305 survival after blastocyst transfer. While average embryo weights were similar (Fig. 1B), 
306 placental weights were lower in transferred conceptuses compared to controls (Fig. 1C) 
307 suggesting that the blastocyst transfer protocol might alter placental development. 
308 Furthermore, embryo:placenta weight ratios were higher in transferred conceptuses, yet 
309 only significantly so in transferred female conceptuses (p=0.025; Fig. 1D). 
310 To further define the growth phenotype, embryo crown-rump lengths were 
311 measured. While mean lengths were not significantly different between control and 
312 transfer groups (Fig. 1E), frequency distribution curves of crown-rump lengths were 
313 generated (Fig. 1F) to detect specific embryos with abnormal growth. Defective growth 
314 was defined as crown-rump lengths that were >2 standard deviations from the mean 
315 length of control embryos. Regardless of sex, a similar frequency of growth restriction was 
316 observed in control (4.4 – 4.5% of embryos) and transferred conceptuses at E10.5 (5.9% 
317 of embryos, p=0.687; Fig. 1A,F, Table 2). Interestingly, three out of 17 (17.6%) of the 
318 transferred male embryos displayed growth enhancement (Fig. 1A,F, Table 2). This 
319 frequency was not statistically significant (p=0.08), likely due to the small sample size. No 
320 transferred female embryos or control embryos were growth enhanced (Fig. 1F, Table 2) 
321 suggesting that this phenotype might be sexually dimorphic. A lack of correlation between 
322 litter size and crown-rump length in control or transferred litters at E10.5 (Fig. 1G) 
323 suggested that litter size is an unlikely confounder of this study.
324 When all phenotypes (e.g., growth restriction, growth enhancement, developmental 
325 delay) and resorptions were grouped together, fewer embryos were classified as 
326 ‘phenotypically normal’ (PN) in the transferred group (55.8%; p<0.001) compared to 
327 controls (91.6%; Table 2). When the analysis was restricted to conceptuses with PN 
328 embryos (Fig. 1A,F), average weight of the associated placentas remained lower in 
329 transferred conceptuses compared to controls, regardless of sex (p<0.004; Fig. 1J). 
330 Despite this, average embryo weight was normal in PN males (p=0.472) and higher in PN 
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331 females (p=0.019) compared to same-sex controls (Fig. 1I). These data suggested that 
332 the placentas of transferred conceptuses, though small, were potentially more efficient in 
333 both sexes. This hypothesis was reinforced by increased embryo:placenta weight ratios in 
334 PN transferred conceptuses (p<0.002; Fig. 1K). Future histological and functional 
335 analyses are required to confirm this hypothesis. Altogether, these data imply that after 
336 blastocyst transfer, normal growth trajectory of the embryo is likely reliant upon functional 
337 compensation by the placenta. 
338
339 Blastocyst transfer alters the placental transcriptome at E10.5 
340 Typically, large litters result in smaller conceptuses, particularly in late gestation when 
341 competition for maternal resources is highest (Ishikawa et al. 2006). In our data at E10.5, 
342 we observed that neither embryo crown-rump length (Fig. 1G) nor placenta weight (Fig. 
343 2A) correlated with litter size. These data further demonstrate that litter size is an unlikely 
344 confounder in our study. 
345 We sought to determine the effect of blastocyst transfer on the placental 
346 transcriptome. A genome-wide transcriptome analysis was performed via RNA-sequencing 
347 to determine differential mRNA expression in whole placentas from control (N=4) or 
348 transferred (N=4) C57Bl/6 conceptuses at E10.5. Since the placenta transcriptome is 
349 known to exhibit some sexual dimorphism (Gonzalez et al. 2018) and due to tissue 
350 availability, only male placentas associated with PN embryos were selected for analysis. 
351 cDNA libraries generated from placental RNA were sequenced using the NextSeq500 
352 (Illumina) platform and bioinformatically analysed.
353 A principal component analysis revealed that, based on RNA content, the placentas 
354 of control and transferred conceptuses clustered separately (Fig. 2B). Differential mRNA 
355 expression was determined when log2[fold change] >1 (i.e., fold change ≥2; p<0.05). 
356 Remarkably, 543 genes were differentially expressed in transferred placentas compared to 
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357 controls including 355 up-regulated and 188 down-regulated genes (Fig. 2C-D). We 
358 selected 27 (5.0%) DEGs for validation via qRT-PCR using RNA isolated from 
359 independent whole male placentas (N=4-7 placentas/group) (Fig. 2E-F, 4B). Thirteen out 
360 of 17 genes that were down-regulated in the RNA-sequencing experiment were also 
361 down-regulated in the qRT-PCR analysis (p<0.05), with the remaining four genes showing 
362 a strong downward trend (Fig. 2E, 4B). Furthermore, eight out of 10 up-regulated genes 
363 were also statistically validated by qRT-PCR (p<0.05; Fig. 2F, 4B). Therefore, the RNA-
364 sequencing experiment was deemed robust and reliable.
365
366 All major placental cell types represented by differentially expressed genes
367 To determine if blastocyst transfer affected gene expression in specific placental cell 
368 types, we performed an extensive literature and database search to resolve the spatial 
369 expression of the DEGs in mouse placentation sites. The primary resource for this analysis 
370 was a published single cell RNA-sequencing data set on whole C57Bl/6 mouse placentas 
371 at E14.5 (Han et al. 2018). Although the developmental stage assessed in Han et al. 
372 (2018) differed slightly from our analysis, the data can be used as a predictive indicator of 
373 spatial expression. 
374 Of the 543 DEGs that were identified, placental expression of the majority of DEGs 
375 (362 genes) is not currently described in mouse. Expression of 102 DEGs has been 
376 reported in the C57Bl/6 mouse placenta at term but without information about cell type 
377 specificity (Yue et al. 2014) (Supplementary table 2). Spatial expression of the remaining 
378 79 genes has been characterized. In several cases (14 DEGs), gene expression occurred 
379 in more than one placental cell population (Fig. 3A, Supplementary table 3). Additionally, 
380 most cell types present in the mouse placentation site were represented by DEGs (e.g., 
381 trophoblast, endothelial, endoderm, stromal, decidual, hematopoietic lineages) (Fig. 3A, 
382 Supplementary table 3) further indicating that blastocyst transfer is unlikely to affect a 
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383 single cell lineage. A similar proportion of DEGs were detected in trophoblast cells (26/79 
384 DEGs, 32.9%) and endodermal cells (27/79 DEGs, 34.2%), though fewer DEGs were 
385 detected in the decidua (19/79 DEGs, 24.1%) and fetal vascular endothelium (5/79, DEGs, 
386 6.3%) (Fig. 3A, Supplementary table 3). It will be important in the future to validate the 
387 spatial expression of these genes in the mouse placentation site at E10.5 using in situ 
388 hybridisation. Overall, this result suggested that blastocyst transfer caused broad 
389 transcriptional changes throughout the mouse placentation site at midgestation even when 
390 the embryo was considered phenotypically normal.
391
392 DEGs were enriched for genes associated with placental growth and function
393 The primary annotation terms enriched in placentas from transferred conceptuses at E10.5 
394 included genes important for placental development, growth and function (Fig. 3B). 
395 Enrichment groups included genes associated with specific mammalian phenotypes (e.g., 
396 decreased vascular permeability, abnormal visceral yolk sac, abnormal lipid and glucose 
397 homeostasis, and decreased circulating IGF1 and insulin levels), and genes required for 
398 specific biological processes (e.g., cell adhesion, response to decreased oxygen levels, 
399 and negative regulation of cell proliferation and growth) (Fig. 3B). At least 13 DEGs 
400 identified are important for placental development and/or function as evidenced by gene 
401 knockout and over-expression studies (Table 3). Furthermore, 31 DEGs encode for 
402 proteins with nutrient transporter activity (24/31 [77.4%] DEGs were up-regulated; 7/31 
403 [22.6%] DEGs were down-regulated) including gap junction protein 1 (Gjb1), and those 
404 important for lipid and fatty acid transport (Slc27a2, Mttp, Apom, Amn) and glutamate 
405 transport (Slc17a8, Slc7a11) (Table 4). Together, these data supported the hypothesis 
406 that blastocyst transfer results in structural and functional compensation by the placenta 
407 with the aim of maintaining embryo growth. Whether changes in gene expression lead to 
408 altered protein expression or activity in transferred placentas requires exploration. 
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409
410 Dysregulation of DNA methylation at proximal promoter regions by blastocyst 
411 transfer is unlikely to disrupt transcription 
412 The mechanism by which blastocyst transfer alters gene expression is not well 
413 understood, though epigenetic dysregulation has been implicated (Choux et al. 2015, 
414 Canovas et al. 2017). To examine the potential sensitivity of the DEGs to changes in DNA 
415 methylation, we first evaluated whether the top 50 down-regulated genes (fold change > 
416 3.1) and top 50 up-regulated genes (fold change > 6.7) contained intragenic CpG islands 
417 or proximal promoter CpG islands (within 20 kb of the gene) (Fig. 4A). This result was 
418 compared to 50 randomly selected genes as a proxy for the rest of the genome. CpG 
419 islands are usually associated with methylation and are known to regulate gene 
420 expression (Gardiner-Garden & Frommer 1987). We identified CpG islands using the CpG 
421 island track within the UCSC Mouse Genome Browser (Haeussler et al. 2019; see 
422 methods). While this initial analysis did not determine whether the CpG islands were 
423 methylated or directly regulate gene expression, it highlighted the potential for gene 
424 dysregulation when methylation patterns are altered. Compared to the genome, both up- 
425 and down-regulated gene sets were less likely to contain intragenic CpG islands (22-30% 
426 of DEGs compared of 55% of genes genome-wide, p<0.005; Fig. 4A). Moreover, down-
427 regulated DEGs were less frequently associated with proximal promoter CpG islands (26% 
428 of DEGs, p=0.025) than both up-regulated DEGs and the genome (42% of genes; Fig. 
429 4A). Overall, these findings suggested that genes that were differentially expressed after 
430 blastocyst transfer were less likely to be cis-regulated by intragenic or proximal promoter 
431 CpG methylation compared to the genome at large. 
432 We identified 15 DEGs whose regulation was directly linked to CpG methylation at 
433 specific genomic locations by other studies (Table 5). Based on the published data and 
434 our RNA-seq results, we predicted that seven of these DEGs should be associated with 
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435 CpG hypomethylation and eight DEGs with CpG hypermethylation (Table 5). We sought to 
436 test CpG methylation in two loci (e.g., Prl3d1 promoter and the differentially methylated 
437 region (DMR) associated with the Rasgrf1 gene) via bisulfite pyrosequencing. Due to 
438 tissue availability, bisulfite pyrosequencing was carried out on whole female placentas 
439 (N=5 placentas from 3-4 litters/group), even though the RNA-sequencing experiment 
440 assessed whole male placentas. To rectify potential sex differences, we first verified that 
441 female placentas from transferred conceptuses showed similar dysregulation of DEGs as 
442 male transferred conceptuses by performing qRT-PCR analysis. In all six DEGs assessed 
443 (i.e., Prl3d1, Rasgrf1, Dazl, Cldn11, Tfpi2, Eno2), female and male transferred placentas 
444 showed similar patterns of gene misexpression relative to same-sex controls (Fig. 4B). 
445 Thus, regardless of sex, we expected CpG hypermethylation in the Prl3d1 promoter 
446 (Hayakawa et al. 2012) (Fig. 4C) in transferred placentas since Prl3d1 mRNA expression 
447 was low (Fig. 2D, 4B). Nevertheless, five CpG sites across the Prl3d1 promoter revealed 
448 comparable levels of methylation in non-transferred and transferred placenta groups (Fig. 
449 4D). This methylation pattern was also similar to normal C57Bl/6N placentas without 
450 decidua at E14.5 (Hayakawa et al. 2012) indicating that the presence of decidua in our 
451 placentas was an unlikely confounder. Likewise, we assessed CpG methylation in the 
452 Rasgrf1 DMR (Fig. 4C). Reduced Rasgrf1 mRNA expression in transferred placentas (Fig. 
453 2D, 4B) intimated that hypomethylation of the Rasgrf1 DMR was expected (Yoon et al. 
454 2005). However, four out of five CpGs assessed showed similar levels of methylation in 
455 transferred and control placentas (Fig. 4E). One CpG site in the Rasgrf1 DMR (CpG-5) 
456 was hypomethylated in transferred placentas (20.7 ± 4.1% methylated versus 38.6 ± 4.0% 
457 methylated in controls; p<0.0001; Fig. 4E), but hypomethylation of a single CpG among 
458 many is unlikely to be responsible for increased Rasgrf1 mRNA expression. Altogether, 
459 these data supported the hypothesis that disruption of DNA methylation at promoter 
460 regions by blastocyst transfer might not lead to transcriptional changes in the mouse 
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461 placenta at E10.5. 
462
463 Some DEGs cluster in the genome implying common transcriptional regulation
464 Next, we determined the chromosomal location of DEGs (fold change >2) including 355 
465 up-regulated and 188 down-regulated genes (Fig. 5A). While the DEGs were distributed 
466 throughout the genome, we observed several genomic clusters of two or more DEGs (Fig. 
467 5A). Gene clustering was unlikely to occur by chance because no clusters were identified 
468 in a group of 60 randomly selected genes. This observation suggested that some DEGs 
469 might share common long-range, cis-acting regulatory mechanism(s). To explore this 
470 hypothesis further, we analysed a published data-set that defined enhancer-promoter units 
471 (EPUs) in C57Bl/6 placentas at term based on an active chromatin state at enhancers (i.e., 
472 enrichment for H3K4 monomethylation (me1) and H3K27 acetylation (ac)) and occupancy 
473 of RNA polymerase II at promoters (Shen et al. 2012). From this data, we predicted DEGs 
474 (fold change >2) that were coordinately regulated by cis-acting elements in the placenta 
475 based on their EPU co-localisation. A total of 33 EPUs were identified containing at least 
476 two DEGs and a maximum of eight DEGs (mean [± s.d.]: 2.6 ± 1.4 DEGs/EPU; Fig. 5A-B, 
477 Supplementary table 4). We found that 15.8% (86/543) of DEGs fell within shared EPUs 
478 and, in general, all DEGs within a single EPU showed a similar direction of misexpression 
479 (Supplementary table 4). This finding supported the hypothesis of shared long-range, cis-
480 acting regulation of some DEGs and highlighted the potential importance of histone 
481 modifications in this process. Chromatin immunoprecipitation followed by DNA sequencing 
482 (ChIP-seq) will be required to explore whether blastocyst transfer affects histone 
483 modifications in the placenta. 
484
485
486 DISCUSSION
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487 Evidence suggests that ART might influence pregnancy outcome in an adverse manner, 
488 yet the mechanism is not well understood. Here we showed that blastocyst transfer after 
489 natural mating of healthy mice is sufficient to restrict placental growth at midgestation even 
490 though the associated embryos were of normal size, or even larger, on average. This 
491 phenotype corresponds with a placental transcriptome that was enriched for genes 
492 implicated in labyrinth formation, growth, vascular development, and transport function, 
493 and implies compensation by the placenta to increase its functional efficiency. Therefore, 
494 even minimal embryo manipulation by a technique used in all ART procedures has 
495 developmental implications for the placentation site and embryo. Our data suggest that 
496 changes in DNA methylation at proximal promoter regions might not disrupt gene 
497 expression in the placenta after blastocyst transfer. This is because DEGs were less likely 
498 to associate with CpG islands within a 20 kb region than genes in the genome at large and 
499 DNA methylation patterns remained unchanged in at least two DEG loci compared to non-
500 transfer controls. The genomic clustering of some DEGs warrants further investigation of 
501 the effects of blastocyst transfer on long-range, cis-acting epigenetic mechanisms, 
502 including histone modifications and DNA methylation. 
503 Fetal growth is contingent upon a functioning placenta since it is the interface 
504 between the maternal and fetal circulations, facilitating gas and metabolic exchange, and 
505 hormone production (Watson & Cross 2005). After blastocyst transfer, we observed 
506 placentas that were small at E10.5 suggesting delayed development and/or reduced 
507 placental growth. Since the associated embryos were of normal developmental stage and 
508 size, the placentas may have adjusted their functional performance to protect the embryo 
509 growth trajectory. To achieve this, the placenta might respond to fetal requirements by 
510 altering its structure, endocrine function, and/or nutrient transport capacity through 
511 transcriptional changes. 
512 In the mouse, the labyrinth layer is the exchange barrier composed of a complex 
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513 network of trophoblastic villi that separate the fetal capillaries from the maternal blood 
514 circulation (Watson & Cross 2005). We observed several genes associated with labyrinth 
515 formation that were up-regulated after blastocyst transfer including those involved in 
516 branching morphogenesis and vascularization as determined by genetic knockout mice 
517 (Sun et al. 1998, Xue et al. 1998, Liu & LeRoith 1999, Stumpo et al. 2004, Bell et al. 2006, 
518 Smith et al. 2006, Fotopoulou et al. 2010, Goyal et al. 2010, Perez-Garcia et al. 2018). 
519 These transcriptional changes might promote branching of additional villi and/or increased 
520 vascular density of existing villi (Wu et al. 2003) to improve the surface area for exchange. 
521 In support of this hypothesis, increased placental vascular density is apparent after IVF 
522 (together with embryo transfer) in bovine and ovine conceptuses (Miles et al. 2005, 
523 Grazul-Bilska et al. 2014). IVF followed by blastocyst transfer in mice might lead to 
524 increased branching morphogenesis since an initially small placenta at E12.5 develops 
525 into a large placenta by late gestation (Delle Piane et al. 2010, Bloise et al. 2012). To fully 
526 understand the effects of blastocyst transfer alone on mouse placental villus structure, a 
527 detailed morphological analysis is required. Additionally, it will be interesting to explore 
528 how specific transcriptional profiles relate to the morphological differences.
529 Alternatively, placentas are capable of stimulating nutrient transport to compensate 
530 for poor placental growth (Constancia et al. 2002). Similar to studies of whole mouse 
531 placentas at E15.5 after IVF without superovulation  (Bloise et al. 2012), we observed 
532 many up-regulated genes in transferred placentas that encode for transport proteins (e.g., 
533 Gjb1, gap junction protein; Slc7a9, L-cystine transport; Slc27a2, fatty acid transport; 
534 Slc7a11, cysteine/glutamine transport; Apom, lipid transport, etc.) when compared to non-
535 transferred controls. This implies functional compensation by a small placenta in response 
536 to fetal requirements. Placental transport assays (Constancia et al. 2002) will be required 
537 to more fully understand the degree to which transcriptional up-regulation leads to a 
538 functional increase in nutrient transport across the placenta. Furthermore, whether the 
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539 transferred placenta is able to continue to compensate in later stages of gestation as the 
540 demands by the fetus increase remains to be determined.
541 It is possible that blastocyst transfer affects other placental regions (e.g., junctional 
542 zone or decidua). For instance, we identified four placenta prolactin cluster genes (Prl2c2, 
543 Prl3d1, Prl7a1, Prl8a1), which are solely expressed in the spongiotrophoblast cells and 
544 TGC subtypes of the mouse placenta (Simmons et al. 2008) and were down-regulated in 
545 transferred placentas. Normally, the promoter of the Prl3d1 gene (also known as Pl1) is 
546 hypomethylated in the mouse placenta compared to adult organs (Hayakawa et al. 2012). 
547 While DNA methylation was normal in the Prl3d1 promoter of transferred placentas, it is 
548 possible that changes in histone modifications together with DNA methylation in a more 
549 broadly defined region surrounding the Prl3d1 gene might be implicated. Further analysis 
550 of chromatin marks in this genomic region is required. Alternatively, reduced differentiation 
551 of progenitor cells within the ectoplacental cone of transferred conceptuses might lead to 
552 fewer parietal-TGCs (Prl3d1+ cells) and/or spongtiotrophoblast cells (Prl2c2+, Prl7a1+, or 
553 Prl8a1+ cells) at E10.5 and thus reduced expression of these genes would result. In 
554 support of this hypothesis, Aldh3a1 and Il33, genes that regulate the differentiation and 
555 function of the progenitor cells within the ectoplacental cone (Nishiyama et al. 2015, Wang 
556 et al. 2017), were also down-regulated in transferred placentas. To better understand the 
557 effects of blastocyst transfer on trophoblast differentiation, a histological examination and 
558 systematic assessment of trophoblast marker gene expression is required. Regardless, 
559 altered expression of prolactin cluster genes might have implications for placenta 
560 morphology, metabolism, and hormone production (Simmons et al. 2008, Woods et al. 
561 2018). 
562 Many researchers studying the epigenetic effects of ART have performed directed 
563 analyses of imprinted regions in placentation sites from mid- to late gestation (reviewed by 
564 Choux et al. 2015) as a read-out of functional changes in genome-wide DNA methylation. 
Page 22 of 53Accepted Manuscript published as REP-19-0293.R2. Accepted for publication: 18-Nov-2019
Copyright © 2019 Society of Reproduction and FertilityDownloaded from Bioscientifica.com at 11/29/2019 03:31:29PM
via University of Cambridge
23
565 Here, we performed a genome-wide approach to assess the placental transcriptome and 
566 identified only three misexpressed genes associated with distinct imprinted control regions 
567 (i.e., Rasgrf1, Cobl, Tfpi2) (Yoon et al. 2005, Monk et al. 2008, Shiura et al. 2009). 
568 Therefore, unlike more invasive ART procedures, blastocyst transfer might not alter DNA 
569 methylation to a great extent in the whole placenta at E10.5. Beyond imprinted genes and 
570 in support of this hypothesis, fewer misexpressed genes in transferred placentas were 
571 associated with intragenic and proximal promoter CpG islands than the rest of the genome 
572 implicating long-range cis-acting epigenetic mechanisms. Furthermore, we showed that at 
573 least two DEGs with known regulation by CpG methylation in the placenta (i.e., Prl3d1 and 
574 Rasgrf1) (Yoon et al. 2005, Hayakawa et al. 2012) displayed normal DNA methylation 
575 patterns. A whole methylome analysis (e.g., whole genome bisulfite sequencing) will better 
576 address whether blastocyst transfer alters DNA methylation in transferred placentas to 
577 cause the widespread transcriptional changes.
578  Our data suggests that blastocyst transfer might disrupt other epigenetic 
579 mechanisms, such as histone modifications. The effects of ART on histone modifications 
580 are little studied and not well understood. Increased histone acetylation (e.g., H3K9ac, 
581 H3K14ac) in mouse zygotes is associated with superovulation (Huffman et al. 2015). 
582 Whether these changes are maintained by placenta cell lineages and influence gene 
583 expression is unclear. While we did not assess the effects of blastocyst transfer on histone 
584 modifications directly, we showed that some DEGs shared cis-acting regulatory elements 
585 in the placenta, the identification of which was largely based on the enrichment of histone 
586 modifications and RNA polymerase binding (Shen et al. 2012). As a result, these clustered 
587 DEGs might be sensitive to regional changes in histone modifications at key stages of 
588 development. Interestingly, four DEGs in transferred placentas (i.e., AU022751, Myocd, 
589 Chd5, Pygo1) are regulators of histone modifications (Cao et al. 2005, Fiedler et al. 2008, 
590 Potts et al. 2011, Zhuang et al. 2014, Maier et al. 2015, Kloet et al. 2016). Indeed, the 
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591 dysregulation of proteins involved in chromatin remodeling has implications for widespread 
592 transcriptional dysregulation beyond the EPUs identified. Therefore, our study sets the 
593 stage for future analyses including ChIP-seq experiments, which will be required to explore 
594 the effects of blastocyst transfer on the regulation of histone modifications.
595 How blastocyst transfer alters placental gene expression remains unclear. The 
596 establishment of epigenetic marks is initiated at the blastocyst stage (Hanna et al. 2018). 
597 Therefore, it is possible that the stress of a brief culture period, embryo handling, and/or 
598 placement into a new uterine environment during this key epigenetic milestone is sufficient 
599 to alter epigenetic marks and subsequent gene expression required for cells to 
600 differentiate and function. Since all ART require blastocyst transfer, it will be important to 
601 tease apart the transcriptional and developmental effects of the transfer process from the 
602 more invasive techniques. Furthermore, the ART field will benefit from epigenome-wide 
603 analyses of placentas derived from these technologies including DNA methylation together 
604 with histone modifications with the aim of looking beyond imprinted loci. This will allow for 
605 a holistic picture of the epigenetic framework that gives rise to transcriptional and 
606 functional changes in the placenta after ART, and thus the immediate and long-term 
607 effects on the fetus. 
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872 FIGURE LEGENDS
873 Figure 1. Blastocyst transfer in mice results in small placentas with a potential for 
874 increased efficiency at E10.5. (A) Images of embryos and placentas from non-
875 transferred and transferred conceptuses at E10.5. Embryonic phenotypes shown include 
876 phenotypically normal (PN), growth enhanced (GE), growth restricted (GR), and 
877 developmentally delayed (DD) as determined by crown-rump lengths and somite pair 
878 counts. Arrowhead indicates where the allantois (i.e., the umbilical cord) was attached to 
879 the placenta. Scale bars: 500 μm. (B-E) Graphs showing (B) embryo weights, (C) placenta 
880 weights, (D) embryo:placenta (E/P) weight ratios, and (E) embryo crown-rump (CR) 
881 lengths in all non-transferred (black circles) and transferred (white circles) conceptuses at 
882 E10.5. Values are shown for male (m) and female (f) conceptuses (N=17-43) and data is 
883 presented as mean ± standard deviation (SD). Independent t test, *p<0.05, ***p<0.001. (F) 
884 Frequency distribution curves of embryo CR lengths as determined by sex for non-
885 transferred (black solid line) and transferred (grey solid line) embryos. Only embryos 
886 staged as E10.5 were considered. Black dotted lines indicate the mean crown-rump length 
887 for non-transferred embryos. Lengths that fall within the grey shading indicate 
888 conceptuses that are grossly phenotypically-normal (PN). Grey dotted lines indicate two 
889 SDs from the control mean. Crown-rump lengths that were greater than two SDs below the 
890 mean were considered GR and greater than two SDs above the mean were considered 
891 GE. (G) Linear regression analysis of litter size versus embryo CR length in control (black 
892 circles) and transferred (white circles) conceptuses. A line of best fit is indicated (dotted 
893 line). (H-K) Graphs showing parameters for PN conceptuses only including (H) embryo CR 
894 length, (I) embryo weight, (J) placenta weight, and (K) E/P weight ratios in non-transferred 
895 (black circles) and transferred (white circles) conceptuses. Data is presented as mean ± 
896 SD and is shown for male (m) and female (f) conceptuses (N=10-43 conceptuses). 
897 Independent t tests, p<0.05, ***p<0.001. 
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898
899 Figure 2. Blastocyst transfer causes differential gene expression in mouse 
900 placentas at E10.5. An RNA-seq analysis was performed on whole male placentas from 
901 non-transferred and transferred experimental groups. N=4 placentas from 3-4 litters per 
902 group were analysed. Placentas assessed via RNA-seq are labeled in panels A, B, and D 
903 with the placenta ID (non-transferred (NT) or transferred (T) followed by the sample 
904 number and letter ID indicating the litter). (A) Graphs plotting litter size versus placental 
905 weight of male and female non-transferred placentas (left panel) and transferred placentas 
906 (right panel). The line of best fit (grey dotted line) is indicated, and the p and R2 values 
907 from a linear regression analysis are shown. Green and blue data points are samples used 
908 in the RNA-seq experiment. (B) Principal component analysis of the RNA-seq data of 
909 whole male placentas from control non-transferred (green circles) and transferred (blue 
910 circles) conceptuses. (C) MA plot revealing 543 differentially expressed genes (DEGs) with 
911 a fold change >log21.0 (i.e., fold change ≥2; p<0.05) in placentas from transferred 
912 conceptuses compared to non-transferred controls. 188 DEGs were down-regulated (blue) 
913 and 355 DEGs were up-regulated (red). (D) Heat map showing differential expression of 
914 selected DEGs in non-transferred (NT) and transferred (T) placentas. Scale shown is 
915 log2[fold change]. Red, gene up-regulation; green, gene down-regulation. (E-F) Validation 
916 of RNA-seq data by qRT-PCR analysis in independent placentas from non-transferred 
917 (black bars) and transferred (white bars) conceptuses. Data is presented as fold change 
918 compared to controls (normalised to 1). N=4-7 placentas per group from 2-4 litters. Graphs 
919 show qRT-PCR data of representative genes that were significantly (E) down-regulated or 
920 (F) up-regulated in transferred placentas. Unpaired t tests with Welch correction or Mann-
921 Whitney tests where appropriate, §p=0.05, *p<0.05, **p<0.01, ***p<0.001. 
922
923
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924 Figure 3. Spatial expression and ontological analyses of DEGs identified in 
925 placentas of transferred mouse conceptuses at E10.5. (A) UpsetR plot summarizing 
926 the predicted spatial expression of 79 DEGs in the mouse placentation site. Data was 
927 largely obtained from a published single cell RNA-sequencing data set on whole mouse 
928 placenta at E14.5 (Han et al. 2018). See also Supplementary table 3. Dark grey bars, up-
929 regulated DEGs; light grey bars, down-regulated DEGs; black circles indicate cell specific 
930 expression; white circle indicate that expression was undetected. TB, trophoblast; Lab TB, 
931 labyrinth trophoblast; EPC TB, ectoplacental cone trophoblast; FVE, fetal endothelial 
932 vascular cells; PE/EC, parietal endoderm or endodermal cells; HPSC, hematopoietic stem 
933 cells; FEC, fetal erythroid cell; Dec, decidua; uNK, uterine natural killer cell. (B) Gene 
934 ontology term enrichment analysis for DEGs in placentas of transferred conceptuses. The 
935 numbers of genes in each term are also given. 
936
937 Figure 4. Alteration of proximal promoter CpG methylation might not disrupt 
938 transcriptional change in the mouse placenta after blastocyst transfer. (A) The 
939 percentage of the top 50 down-regulated DEGs (grey bars, FC >3.1) or up-regulated 
940 DEGs (white bars, FC >6.7) after blastocyst transfer that associate with intragenic or 
941 proximal promoter CpG repeats (within 20 kb region). The percentage of 50 randomly 
942 selected genes is indicated as a proxy for the genome (black bars). Fisher’s exact test, 
943 *p<0.05, **p<0.01, ***p<0.001. (B) Validation of differential gene expression in male (m) 
944 and female (f) placentas from non-transferred (black bars) and transferred (white bars) 
945 conceptuses at E10.5. Data is presented as fold change compared to controls (normalised 
946 to 1; mean ± sd). N=4-7 placentas/group from 3-4 litters. Independent t test. §p=0.05; 
947 *p<0.05; **p<0.01; ***p<0.001. (C) Schematic drawings of the Prl3d1 promoter and 
948 Rasgrf1 differentially methylated region (DMR). Modified from (Yoon et al. 2005, 
949 Hayakawa et al. 2012). Open and closed circles represent unmethylated and methylated 
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950 CpG sites in placental tissue, respectively. a-d represent regions assessed by bisulfite 
951 pyrosequencing in Prl3d1 promoter. (D-E) CpG site-specific methylation (mean ± se) in (D) 
952 the promoter region of the Prl3d1 gene and (E) the Rasgrf1 DMR as determined via 
953 bisulfite pyrosequencing of DNA from control (black squares) and transferred (white 
954 squares) female placentas at E10.5. N=5 placentas/group from 3-4 litters. Independent t 
955 tests when primers spanned a single CpG site (i.e., Prl3d1, regions a, b, d) and two-way 
956 ANOVA with Sidak’s multiple comparisons test when primers spanned two or more CpG 
957 sites (i.e., Prl3d1, region c; Rasgrf1 DMR). ***p<0.001. 
958
959 Figure 5. Clustering of differentially expressed genes (DEGs) in the mouse genome 
960 suggests shared long-range, cis-acting regulatory regions. (A) Schematic karyoplot 
961 representing mouse chromosomes 1-19, X and Y indicating the location of DEGs (log2[fold 
962 change] > 1) in whole placentas after embryo transfer as determined via RNA-sequencing. 
963 Red, up-regulated genes; blue, down-regulated genes. Peaks on the left-hand side of 
964 each chromosome represent the degree of gene density in that genomic region. Yellow 
965 arrowheads indicate enhancer-promoter units (EPUs) containing at least two DEGs. (B-D) 
966 A schematic representation of two neighbouring EPUs (yellow bars) on chromosome 4 
967 including one EPU (right) that contains the DEGs Edn2 and Foxo6. The level of 
968 misexpression of these genes is indicated by the respective red dots on a log2[fold 
969 change] scale. Additional features include: chromosomal location of peaks of enrichment 
970 for placental histone modifications, such as H3K4me1 (purple peaks), H3K4me3 (red 
971 peaks), and H3K27ac (light green peaks) generated using published ChIP-seq data (Yue 
972 et al. 2014), CpG islands (CGIs; green lines) and genes (blue). Grey peaks indicate ChIP-
973 seq input. See also Supplementary table 4.
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Table 1. Embryonic phenotypes before and after blastocyst transfer in mice.
Phenotype at E3.5 before transfer Phenotype at E10.5 after transferRecipient 
Female ID No. of 
embryos 
transferred
Blasto-
cyst 
stage
Morula 
stage
Abnormal
No. of 
conceptuses
at E10.5 
(Implantation 
rate [%])
PN GE GR DD CM R
C57-T1 10 5 4 1 6 (60.0%) 3 1 0 0 0 2
C57-T2 9 6 3 0 0 - - - - - -
C57-T3 10 3 7 0 6 (60.0%) 5 0 0 0 0 1
C57-T4 8 4 4 0 4 (50.0%) 0 0 0 4 0 0
C57-T5 10 4 3 3 6 (60.0%) 6 0 0 0 0 0
C57-T6 9 7 2 0 3 (33.3%) 0 1 1 0 0 1
C57-T7 8 7 1 0 5 (71.4%) 3 0 1 0 0 1
C57-T8 9 5 4 0 0 - - - - - -
C57-T9 8 7 1 0 7 (87.5%) 5 1 0 0 0 1
C57-T10 10 6 4 0 6 (60.0%) 3 0 0 0 0 3
Total 91 48 29 4 43 (47.2%) 25 3 2 4 0 9
E, embryonic day; PN, phenotypically normal; GR, growth restricted; GE, growth 
enhanced; DD, developmentally delayed; CM, congenital malformation; R, resorption.
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Table 2. Phenotypic comparison of non-transferred and transferred mouse conceptuses at 
E10.5
C57Bl/6 non-transferreda C57Bl/6 transferreda
Experimental group
No. of conceptuses assessed at E10.5
Total 95 (10 litters) 43 (8 litters)
Male 44 b 17 b
Female 45 b 17 b
Average No. of conceptuses/litter
Total 9.5 ± 0.4 5.4 ± 0.5***
Male 4.4 ± 0.5 (46.5%) b 2.1 ± 0.5 (39.5%) b
Female 4.5 ± 0.4 (47.4%) b 2.1 ± 0.5 (39.5%) b
Phenotypes
Phenotypically normal
Total 8.6 ± 0.5 (90.5%) 3.1 ± 0.8*** (58.1%)
Male 4.2 ± 0.5 (95.5%) 1.3 ± 0.5*** (58.8%)
Female 4.1 ± 0.4 (91.1%) 1.9 ± 0.5*** (88.2%)
Growth enhanced
Total 0.0 0.4 ± 0.2c (7.0%)
Male 0.0 0.4 ± 0.2c (17.6%)
Female 0.0 0.0
Growth restricted
Total 0.4 ± 0.2 (4.2%) 0.3 ± 0.2 (4.7%)
Male 0.2 ± 0.1 (4.5%) 0.1 ± 0.1 (5.9%)
Female 0.2 ± 0.1 (4.4%) 0.1 ± 0.1 (5.9%)
Developmental delay
Total 0.0 0.5± 0.5 (9.3%)
Male 0.0 0.4 ± 0.4 (17.6%)
Female 0.0 0.1 ± 0.1 (5.9%)
Congenital malformations
Total 0.0 0.0
Male 0.0 0.0
Female 0.0 0.0
Resorptionsb
Total 0.5 ± 0.3 (5.3%) 1.1 ± 0.4 (20.9%)
Male - -
Female - -
aData is presented as average number of conceptuses [± se] per litter unless otherwise 
indicated. Number in brackets indicates the percentage of total conceptuses with each 
phenotype.
bResorptions could not be genotyped for sex due to maternal tissue contamination. 
cp=0.08
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Table 3. Differentially expressed genes in placentas of transferred mouse conceptuses at 
E10.5 that are implicated in growth, placental phenotypes, and/or embryonic lethality 
Gene Gene function
Mouse knockout phenotype or clinical 
characteristics 
[timing of embryonic lethality]
Reference FC
Genetic knockout or decreased expression: defective labyrinth, placental insufficiency and/or FGR
Cubn Receptor mediated 
endocytosis 
Defects in chorioallantoic attachment [E10.5] (Smith et al. 
2006)
2.9
Enpp2 Angiogenesis Defective chorioallantoic attachment [E10.5] (Fotopoulou et 
al. 2010)
2.5
Zfp36l1 RNA binding 
protein 
Failure of chorioallantoic attachment†, reduced 
branching morphogenesis in labyrinth layer, 
small spongiotrophoblast layer [E10.5†]
(Stumpo et al. 
2004, Bell et al. 
2006)
2.1
F2 Maintenance of 
vascular integrity 
Reduced or absent branching morphogenesis in 
labyrinth layer [E10.5†]
(Sun et al. 1998, 
Xue et al. 1998)
3.4
Rpgrip1 Regulator of ciliary 
protein traffic 
Abnormal vasculature in labyrinth at E14.5 [‘Pre-
weaning’ lethality]
(Perez-Garcia et 
al. 2018)
-2.0
Slpi Serine protease 
inhibitor
Down-regulated expression in rat model of 
placental insufficiency [ND]
(Goyal et al. 
2010)
2.5
Igf1 Insulin-like growth 
factor
Severely growth restricted; unknown placental 
phenotype [Perinatal]
(Liu & LeRoith 
1999)
2.2
Increased gene expression: trophoblast phenotype, placental insufficiency, preeclampsia, or FGR
Aldh3a1 Aldehyde 
dehydrogenase
OE in mouse TSCs prevents differentiation into 
Tpbpa+ cells (EPC lineage) [ND]
(Nishiyama et 
al. 2015)
-9.3
Il33 Interleukin Inhibits trophoblast invasion and adhesion in 
vitro [ND]
(Wang et al. 
2017)
-4.0
Tac2 Disintegrin and 
metalloproteinase
Fetal growth restriction in humans associated 
with increased placental expression [ND]
(Ozler et al. 
2016)
-3.1
Crabp2 Retinoic acid 
signaling pathway
OE in endometrial cell line causes decreased 
proliferation of trophoblast spheroids [ND]
(Lee et al. 2011) 2.3
Cp Iron peroxidase Increased placental expression associated with 
pre-eclampsia in humans [ND]
(Guller et al. 
2008)
2.6
Slc9a2 Sodium/hydrogen 
exchanger
Up-regulated in rat model of placental 
insufficiency; unknown placental phenotype 
[Possible embryonic lethality†]
(Goyal et al. 
2010)
2.9
†Incomplete penetrance; FC, fold change in RNA-sequencing experiment; OE, 
overexpression; E, embryonic day; ND, not determined; FGR, fetal growth restriction; 
TSCs, trophoblast stem cells; EPC, ectoplacental cone.
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Table 4. Differentially expressed genes in placentas of transferred mouse conceptuses at 
E10.5 that encode for proteins with transporter function
Gene Fold Change Gene Function
Down-regulated genes
Trpm2 -10.1 Calcium channel
Slc28a2l 
(Gm14085)
-5.15 Purine nucleoside transporter
Clca3a1 -3.90 Calcium-activated chloride channel
Slc17a8 -3.00 L-glutamate transporter
Ndufa4l2 -2.93 NADH dehydrogenase [ubiquinone], mitochondria
Slc28a2 -2.03 Sodium-coupled purine nucleoside transporter
Kcnab2 -2.03 Voltage-gated potassium channel, NADH oxidation
Up-regulated genes
Kcnd2 5.13 Voltage-gated potassium channel
Kcne3 3.91 Voltage-gated potassium channel
Kcnj12 3.07 ATP-sensitive inward rectifier potassium channel
Atp6v1c2 2.89 Proton-exporting ATPase, phosphorylative mechanism
Slc9a2 2.87 Sodium/hydrogen exchanger
Slc13a5 2.87 Sodium-dependent citrate transporter
Gjb1 2.84 Gap junction protein
Slc7a9 2.72 Sodium-independent L-cystine transporter
Abcc6 2.68 ATP-binding cassette transporter
Cftr 2.62 ATP-gated chloride channel
Slc27a2 2.60 Fatty acid transporter
Hcn4 2.58 Cyclic nucleotide-gated potassium channel
Slc7a11 2.57 Cysteine/glutamine transporter
Cacna1b 2.56 Voltage-gated calcium channel 
Jph2 2.42 Calcium channel
Slc39a8 2.31 Zinc ion transporter
Trpm3 2.31 Cation channel
Mttp 2.30 Microsomal triglygeride transfer protein
Kcnk2 2.21 Potassium channel
Asic2 2.14 Voltage-gated sodium channel
Apom 2.09 Lipid transport
Scnn1g 2.07 Amiloride-sensitive sodium channel
Amn 2.04 Cobalamin and lipid transport
Slc4a1 2.03 Chloride/bicarbonate exchanger
Page 38 of 53Accepted Manuscript published as REP-19-0293.R2. Accepted for publication: 18-Nov-2019
Copyright © 2019 Society of Reproduction and FertilityDownloaded from Bioscientifica.com at 11/29/2019 03:31:29PM
via University of Cambridge
Table 5. Differentially expressed genes in placentas from transferred mouse conceptuses 
at E10.5 with known regulation by DNA methylation
Gene 
name Function 
Known characteristics of 
epigenetically regulated expression FC
Predicted 
CpG 
methylation*
Ref.
Down-regulated genes 
Trpm2 Cation channel Methylation of inner CpG island: gene 
repression
-10.1 Hyper (Orfanelli et al. 
2008)
Klra4 Killer cell lectin-
like receptor; cell 
adhesion 
Promoter hypomethylation: gene 
activation
-8.8 Hyper (Rouhi et al. 
2009)
Dazl RNA binding 
protein 
Promoter methylation: gene repression -5.0 Hyper (Hackett et al. 
2012)
Prl8a1 Prolactin hormone 
family
Placenta-specific promoter 
hypomethylation: gene activation
-2.9 Hyper (Hayakawa et 
al. 2012)
Prl7a1 Prolactin hormone 
family 
Placenta-specific promoter 
hypomethylation: gene activation
-2.9 Hyper (Hayakawa et 
al. 2012)
Rasgrf1 Guanine 
nucleotide-
releasing factor 
(Imprinted) Paternally-inherited allele is 
methylated and biallelically expressed 
in the placenta; methylation leads to 
gene activation
-2.7 Hypo (Yoon et al. 
2005, Dockery 
et al. 2009)
Kazald1 Insulin growth 
factor binding 
protein family
Promoter hypomethylation: gene 
activation
-2.3 Hyper (Wang et al. 
2013a)
Prl3d1 Prolactin hormone 
family
Placenta-specific promoter 
hypomethylation: gene activation
-2.0 Hyper (Hayakawa et 
al. 2012)
Up-regulated DEGs 
Edn2 Angiogenesis Hypomethylation of intragenic region: 
gene activation
7.2 Hypo (Wang et al. 
2013b)
Cldn11 Gap junction 
protein
Promoter hypermethylation: gene 
repression
5.9 Hypo (Agarwal et al. 
2009)
Eno2 Glycolysis Promoter hypermethylation: gene 
repression
5.7 Hypo (Wang et al. 
2014)
Inhba TGFβ signaling 
pathway
Promoter hypermethylation in human 
placenta: gene repression
4.4 Hypo (Wilson et al. 
2015)
Cfb Complement 
factor
Promoter hypermethylation: gene 
repression; in human placenta, 
promoter hypomethylated upon CytoT 
to SynT differentiation
4.4 Hypo (Yuen et al. 
2013)
Tfpi2 Serine protease (Imprinted) Paternally-inherited allele is 
methylated at the ICR, maternally-
inherited allele expressed the placenta 
3.1 Hypo (Monk et al. 
2008)
Cobl Actin interacting 
protein
(Imprinted) Tissue-specific parentally-
biased expression; methylation on 
maternally-inherited allele at Grb10 
DMR in yolk sac results in Cobl 
expression from the maternal allele 
2.6 Hyper (Shiura et al. 
2009)
*Predicted change in CpG methylation based on differential expression observed in RNA-
sequencing experiment and published data. FC, fold change; ICR, imprinting control 
region; hypo, hypomethylated; hyper, hypermethylated; CytoT, cytotrophoblast; SynT, 
syncytiotrophoblast.
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1 Supplementary Table 1. Primer sequences (mouse)
RT-qPCR primers
Mouse 
gene name Forward primer (5’3’) Reverse primer (5’3’) Ref.
Adamdec1 GAGGGCTTGAGAACAACCAGA GCCCCAGAAGATGCTTGGT -
Aldh3a1 TCCTGCTCGAGATCTTCTCTTAC GGAGGTGCCACATGACTTTAGG (Nishiyama et al. 2015)
Ang2 GAAAGGAAGCCCTTATGGACGA ATCTGAACCCTTTAGAGGCTCG -
Calcoco2 GGCTGCTGTTCCTGGACTT TCAGTGAGGGTGTAATAGCACAT -
Ccl1 GACATTCGGCGGTTGCTCTA GTAAGCATGCTCTTGCTGTCAAC -
Clca3a1 ACCCCGAGGCAGAGTCTTT CACATTGGTGCCAGTGATCC -
Cldn11 TCCCCACCTGCCGAAAAATG ACGTAGCCTGGAAGGATGAGG -
Ctla4 CCATGCCCGGATTCTGACTT GGACTTCTTTTCTTTAGCATCTT
GC
-
Dazl CTAGGCAGCCACCTCACGTA GAAGTTGTGGCAGACATGATGG -
Eno2 CCTGGAACTAAGGGATGGGG GGTTGTCCAGTTTCTCCTGC -
G530011O0
6Rik
TTTAGGCACAGGCATCGGAA AGCATTTCGGTGAAGCAGGA -
Gm773 TGGAAACTTAAGCCTGCATTTGT TGCTGTAAGTGTAGAGTGTGCT -
Il33 AACTCCAAGATTTCCCCGGC TTATGGTGAGGCCAGAACGG -
Klk9 GCTGGCCTCTTCTACCTCAC GACCCACAGGTACGGCTTTC -
Klra7 CTCTCCAATGAGTGTAAAAGTGC
AA
AGCTTTGGGGGACCAGAGTA -
Klra8 TTCTTCTTGGAGCCTCTTAGGG AAAATATGTCCTGTGTCTCCACC -
Klrb1c GAGTGTCTTAGTGCGAGTCTTAG
T
TTGTGGGCACTCTAAATTAACTG
AA
-
Mndal AAGTGGAGGGGAGTGGACAA TTGGTGACCTTGATCTTGACGA -
Ndufa4l2 TAAAAAGACACCCTGGGCTCAT TGGGTTGTTCTTTCTGTCCCA -
Pianp CACCAGGCATGCAGTAAAGG GAGCAGGTGGTAATACGGACA -
Prl3d1 GGAGCCTACATTGTGGTGGA CATTCCTGCGGAGCCTGAAA -
Ptafr TGAGCTCCTCCTACAGGCAT TCGGAAAGAGCGTGTATCGAA -
Ptgdr CCTGCCTTTAATTTATCGTGCGT GATGAAGATCCAGGGGTCCAC -
Rasgrf1 CAAGAGGAGTGCGGACAACC GCGCGCGTTTACAGATACTTC -
RNAse2a AGACTGGGAAACATGGGTCTGG ATGCTGGATGTCAAACCACCG -
Tfpi2 GCTCCGTTCTTGGTCTCACT TAGAACTTGGGGATGAGGGC -
Bisulfite pyrosequencing primers
Location Forward primer Reverse Primer Sequencing primer
Prl3d1 
promoter:
     set a [biotin]-TTAGATTATATG 
GGGGATATGTAGTATG
TCCTTAAAAATTATTAACATCCTC
TTTACA
ACATCCTCTTTACATTTAAC
     set b TGTGTTAAATGTAAAGAGGAT
GTTAATAAT
[biotin]-ACCAAACTATA 
CCTAAACCCA
AATGTTGTTTATTAATAGATA
TTGA
     set c TTGGAGTAAATGTATATTGTG
AGATGT
[biotin]-ACAACAACAA 
TTACATTCCTACTAT
AAATAAGTATTTTATTAAGTA
ATAG
     set d ATTGTTGTTGTTGGTGTTAAG
T
[biotin]-CCAAAAACAAA 
AACATTACTTACAAATT
TGTTATGGTGTTTATTGAAG
Rasgrf1 
DMR
GGGAAGATTATTAGTTGGGGA
GGTG
[biotin]-CAACAAAAACC 
AAAATATCAATCCTAAC
ATTAGAGTTAAATATAAAGAA
TGG
2
3 All primers are listed in the 5’ to 3’ orientation
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1 Supplementary Table 2. DEGs with known general expression in C57Bl/6 mouse 
2 placentas at term (Yue et al. 2014) 
Gene 
name FC Gene function
Gene 
name FC Gene function
4930523C
07Rik
2.59 Unknown, protein coding Jph2 2.42 Junctional membrane complex 
protein
A2ml1 6.63 Peptidase inhibitor Kank4 3.13 Cytoskeleton
Adamts5 2.76 Disintegrin and 
metalloproteinase
Kazald1 -2.25 Insulin-like growth factor 
binding 
Adcy2 4.01 Adenylate cyclase Kcne3 3.91 Potassium channel activity
Aff2 2.51 Transcriptional activator Klb 3.97 FGF signaling pathway
Adgre1 2.03 G protein-coupled hormone 
receptor
Klrd1 -2.71 Killer cell lectin-like receptor; 
cell adhesion
Aldh1l2 -2.21 One-carbon metabolism 
(mitochondria)
Krt23 2.19 Intermediate filament
Apbb1ip -2.13 Ras signaling pathway Kynu 4.64 NAD cofactor biosynthesis
Apobec1 2.57 Cytodine deaminase Ltb4r1 -2.71 G protein-coupled receptor 
activity
Arhgef26 2.37 Rho-guanine nucleotide 
exchange factor
Lst1 2.09 Membrane protein
Arsk 3.00 Sulfatase, hormone 
biosynthesis
Mid1 -2.27 Cytoskeleton
B3gat2 -2.55 Carbohydrate metabolism Mndal -2.96 RNA polymerase
Btg3 -2.86 Transcription factor binding 
protein
Ms4a4b -3.71 Membrane protein
C1qtnf1 2.21 MAPK pathway Ms4a6c 2.09 Membrane protein
Ccdc3 2.29 TNFα regulation Myocd 3.61 Transcription factor
Cd53 -2.17 Integrin binding, involved in 
cell growth
Naip6 -2.17 Apoptosis inhibitory protein
Cmc4 -2.00 Mitochondrial protein import Ntrk1 -2.32 Kinase in MAPK pathway
Chmp4c 3.89 Chromatin modifying 
protein, mitosis
Osm -2.04 Secreted cytokine; growth 
regulator
Clca3a1 -3.90 Calcium-activated chloride 
channel
Otoa -2.63 Predicted adhesion protein
Cldn1 3.30 Tight junction Pcdhga1 2.52 Protocadherin
Cfb 4.40 Cell proliferation Pcdhgb7 2.29 Protocadherin
Cobl 2.61 Actin nucleator Pianp 50.8 Cell adhesion
Colgalt2 5.27 Extracellular matrix; PPARγ 
pathway
Pllp 2.37 Ion transport
Crabp2 2.32 Retinoic acid signaling 
pathway
Ptafr 4.85 G-protein coupled receptor 
activity
Csdc2 4.62 RNA-binding factor; histone 
synthesis
Ptgs2 -2.25 Prostaglandin synthesis
Ctla4 -5.52 Cytotoxic T-lymphocyte-
associated protein
Rai2 2.00 Retinoic acid signaling 
pathway
Dpp4 2.32 Adenosine deaminase Rasgrf1 -2.70 Ras protein signal transduction 
pathway
Efcab7 2.36 Hedgehog signalling Rgs1 -4.34 Regulator of G protein 
signaling
Egln3 -2.45 HIF-1 signaling pathway Rnf150 7.53 Ubiquitin protein ligase activity
Eno1b 4.73 Glycolysis Robo2 3.41 Cell migration
Enpep 2.20 Aminopeptidase Schip1 2.13 Estrogen metabolism
Fam20a 2.13 Unknown Slc7a11 2.57 Cysteine and glutamate 
transport
Fam189a2 3.20 Unknown Slc9a2 2.87 Na+/H+ transporter
Fam196a 3.89 Unknown Slc27a2 2.60 Fatty acid transport
Far2 -2.03 fatty-acyl-CoA reductase Slc28a2 -2.03 Na-coupled purine nucleoside 
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activity transporter
Fbn1 2.38 Fibrillin Slit3 2.32 Slit/Robo pathway
Galnt2 2.95 Glycosyltransferase Sorbs1 2.28 Insulin signaling
Gpr19 2.46 G protein coupled receptor Spon1 2.39 Cell adhesion
Gpr141 -2.27 Rhodopsin G protein-
coupled receptor
Stom 2.12 Membrane protein
Gpr183 -3.60 G protein-coupled receptor Sytl3 -2.53 Exocytosis
Grap2 2.32 GRB2-related adaptor 
protein
Tfpi -2.57 Tissue factor pathway inhibitor
Gucy2c -2.34 cGMP biosynthesis Thbs1 2.15 Thrombospondin
Gxylt2 3.03 EGF pathway Thbs2 2.69 Thrombospondin
Hipk2 2.19 Negative regulator of BMP 
pathway
Trim5 -2.01 E3 ubiquitin-ligase
Hkdc1 2.57 Glucose metabolism Trim55 -2.37 Cytoskeleton
Hnf4a 2.66 Transcription factor Trpm2 -10.1 Cation channel 
Hspb7 16.7 Chaperone Tspan8 3.46 Integrin binding
Ifi205 -2.15 Transcription factor Unc93a 2.95 Unknown
Il15ra -2.63 Interleukin Wdfy1 2.67 Phosphatidylinositol 3-
phosphate binding protein
Il33 4.04 Interleukin Wscd1 3.07 Sulfotransferase activity
Itgb7 2.34 Integrin; cell-ECM adhesion Zfand4 -2.19 Zinc finger protein
3
4 FC, fold change
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1 Supplementary Table 3. DEGs with known spatial expression in mouse placentas 
Gene 
name FC Gene function
Reported placental expression in 
mouse (stage of development) Ref.
Expression in multiple cell types 
Cp 2.63 Iron homeostasis Lab TB, SpA-TGC, FVE, PE, Dec 
(E14.5)
(Han et al. 2018)
Guca2b 4.67 cGMP biosynthesis Lab TB (E14.5); Dec (E7.5) (McConaha et al. 2011, 
Han et al. 2018)
Lcn2 3.34 Lipocalin 2 Lab TB (E14.5); Dec (E7.5) (McConaha et al. 2011, 
Han et al. 2018)
Ltf 2.28 Lactotransferrin Lab TB (E14.5); Dec (E7.5) (McConaha et al. 2011, 
Han et al. 2018)
Tnfrsf11b 2.17 Tumor necrosis factor-
receptor
Lab TB, Dec (E14.5) (Han et al. 2018)
Gldn -3.77 Extracellular matrix Lab TB, PE (E14.5) (Han et al. 2018)
Trpv6 3.68 Calcium transport Lab TB (S-TGCs), EPC (GlyT) 
(E17.5) 
(Yang et al. 2015)
Ang2 799.3 Ribonuclease Lab TB (S-TGCs), FVE (E17.5) (Geva et al. 2005)
Aldh3a1 -9.29 Aldehyde 
dehydrogenase
TS cells (in vitro), EPC (SpT) 
(E11.5-E17.5), Dec (E7.5)
(McConaha et al. 2011, 
Nishiyama et al. 2015)
Emp1 2.20 Cell adhesion FVE, PE/EC (E14.5) (Han et al. 2018)
Fabp4 2.15 Fatty acid binding 
protein
FVE, Dec (E12.5-E18.5) (Makkar et al. 2014, Han 
et al. 2018)
Rnase4 4.43 Ribonuclease PE/EC, Dec (E14.5) (Han et al. 2018)
Zfp36l1 2.06 Zinc finger protein Allantois, YS (E8.0-E9.5); Dec, 
(E14.5)
(Stumpo et al. 2004, Bell 
et al. 2006, Han et al. 
2018)
Tmem26 3.20 Transmembrane protein HPSC, Stromal cell (E14.5) (Han et al. 2018)
Trophoblast progenitor cell only expression
Gm1821 -2.31 Unknown; protein 
coding
Trophoblast progenitor (E14.5) (Han et al. 2018)
Labyrinth trophoblast cells only expression
Pigr 5.93 EGF pathway Lab TB (E14.5) (Han et al. 2018)
C3 4.60 Complement system; 
ERK1/2 cascade
Lab TB (E14.5) (Han et al. 2018)
Sprr2f 4.09 Epidermis development Lab TB (E14.5) (Han et al. 2018)
Sftpd 3.91 Carbohydrate binding, 
superfactant 
homeostasis
Lab TB (E14.5) (Han et al. 2018)
Fbln2 3.84 Extracellular matrix Lab TB (E14.5) (Han et al. 2018)
Prap1 3.35 Proline rich acidic 
protein
Lab TB (E14.5) (Han et al. 2018)
Fermt1 3.12 Cell adhesion Lab TB (E14.5) (Han et al. 2018)
Robo1 2.90 Slit receptor, cell 
migration
S-TGCs (E13.5, E15.5) (Li et al. 2015)
Srd5a1 -2.52 Steroid 5 α-reductase Lab TB (E14.5) (Han et al. 2018)
Napsa -2.36 Aspartic protease Lab TB (E14.5) (Han et al. 2018)
Slc39a8 2.31 Zinc ion transporter Lab TB (E14.5) (Han et al. 2018)
EPC trophoblast lineage only expression 
Inhba 4.42 TGFβ signaling pathway EPC, P-TGCs (E7.5) (Albano et al. 1994)
Prl8a1 -2.89 Prolactin cluster EPC, SpT, P-TGCs (E12.5-E18.5) (Simmons et al. 2008, 
Han et al. 2018)
Prl7a1 -2.85 Prolactin cluster EPC, SpT, P-TGCs (E8.5-E15.5) (Simmons et al. 2008, 
Han et al. 2018)
Prl2c2 -2.27 Prolactin cluster 
(proliferin)
EPC, SpT, P-TGCs (E8.5-E18.5) (Simmons et al. 2008)
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Prl3d1 -2.02 Prolactin cluster P-TGCs (E8.5-E10.5) (Simmons et al. 2008)
Fetal vascular endothelial (FVE) cell only expression
Enpp2 2.48 Ectonucleotide 
pyrophosphatase/ 
phosphodiesterase
FVE (E14.5) (Han et al. 2018)
Parietal endodermal (PE) cells and endodermal cells (EC) only expression
H2-Q10 13.01 Cell adhesion, antigen 
processing
EC (E14.5) (Han et al. 2018)
Edn2 7.15 Angiogenesis PE (E14.5) (Han et al. 2018)
Itih2 4.03 Serine protease; ECM 
stabilization
EC (E14.5) (Han et al. 2018)
Ambp 4.01 Peptidase inhibitor EC (E14.5) (Han et al. 2018)
Apob 3.74 Apolipoprotein EC (E14.5) (Han et al. 2018)
Myl7 -3.71 Focal adhesions PE (E14.5) (Han et al. 2018)
Lrp2 3.43 Multi-ligand endocytic 
receptor
EC (E14.5) (Han et al. 2018)
F2 3.37 Vascular integrity EC (E14.5) (Han et al. 2018)
Fbp2 3.25 Fructose 
bisphosphotase
PE (E14.5) (Han et al. 2018)
Serpind1 3.07 Inhibitor of proteases EC (E14.5) (Han et al. 2018)
Cubn 2.89 Receptor mediating 
endocytosis
EC (E14.5) (Han et al. 2018)
Gjb1 2.84 Gap junction protein EC (E14.5) (Han et al. 2018)
Slc7a9 2.72 Cysteine transport EC (E14.5) (Han et al. 2018)
Kng2 2.32 Kininogenin EC (E14.5) (Han et al. 2018)
Mttp 2.30 Lipoprotein assembly EC (E14.5) (Han et al. 2018)
Cldn2 2.29 Tight junction protein EC (E14.5) (Han et al. 2018)
Ang 2.21 Angiogenesis PE, EC (E14.5) (Han et al. 2018)
Aifm3 2.14 Oxidoreductase, 
apoptotic process
PE (E14.5) (Han et al. 2018)
Apom 2.09 Apoplipoprotein EC (E14.5) (Han et al. 2018)
Sod3 2.08 Superoxide dismutase EC (E14.5) (Han et al. 2018)
Amn 2.04 Cobalamin transport EC (E14.5) (Han et al. 2018)
Ctsf 2.02 Cathepsin PE (E14.5) (Han et al. 2018)
Stromal cell only expression
Sfrp2 2.84 WNT signaling pathway Stromal cell (E14.5) (Han et al. 2018)
Igf1 2.23 Insulin-like growth factor 
signaling
Stromal cell (E14.5) (Han et al. 2018)
Fxyd1 -2.02 Ion channel protein Stromal cell (E14.5) (Han et al. 2018)
Hematopoietic stem cell (HPSC) only expression
Gm14165 3.30 Unknown; pseudogene HPSC (E14.5) (Han et al. 2018)
Klk8 -3.25 Serine protease HPSC (E14.5) (Han et al. 2018)
Ifitm1 -2.83 Interferon induced 
transmembrane protein
HPSC (E14.5) (Han et al. 2018)
Cd69 -2.13 Calcium and 
carbohydrate binding
HPSC (E14.5) (Han et al. 2018)
Rps23 -2.06 Ribosomal protein HPSC (E14.5) (Han et al. 2018)
Mir703 -2.05 MicroRNA HPSC (E14.5) (Han et al. 2018)
Fetal erythroid cell only expression
Slc4a1 2.03 Chloride/bicarbonate 
exchanger
Fetal erythroid cell (E14.5) (Han et al. 2018)
Decidua (Dec) cell only expression
Pdgfrl 14.46 PDGF receptor-like 
protein
Dec (E7.5) (Ashley et al. 2010)
Fcgbp 9.67 Fc fragment of IgG 
binding protein
Dec (E7.5) (McConaha et al. 2011)
Cldn11 5.87 Tight junction Dec (E14.5) (Han et al. 2018)
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Sfrp5 4.15 WNT signaling pathway Dec (E14.5) (Han et al. 2018)
Cdo1 4.08 SHH co-receptor Dec (E10.5, E14.5) (Rakoczy et al. 2015, 
Han et al. 2018)
Erv3 3.27 Endogenous retrovial 
sequence
Dec (E7.5) (McConaha et al. 2011)
Tfpi2 3.12 Serine protease 
involved in tissue 
remodelling
Dec (E14.5) (Han et al. 2018)
Ear2 3.04 Ribonuclease Dec (E7.5) (McConaha et al. 2011)
Slpi 2.47 Serine protease inhibitor Dec (E14.5) (Han et al. 2018)
Aqp1 2.32 Aquaporin Dec (E14.5) (Han et al. 2018)
Uterine natural killer cell (uNK) expression 
Klrb1b -3.27 Killer cell lectin-like 
receptor
uNK cells (14.5) (Han et al. 2018)
Tff1 -2.75 Secreted protein uNK cells (E14.5) (Han et al. 2018)
Gzmn -2.23 Endopeptidase uNK cells (E14.5) (Han et al. 2018)
Gzmb -2.18 Hydrolyase uNK cell (E14.5) (Han et al. 2018)
Trbc1 2.00 T cell receptor uNK cell (E14.5) (Han et al. 2018)
2
3 Dec, decidua; E, embryonic day; EC, endodermal cell; ECM, extracellular matrix; EPC, 
4 ectoplacental cone; FC, fold change; FVE, fetal vascular endothelium; GlyT, glycogen 
5 trophoblast cell; HSPC, hematopoietic stem cell; Lab troph, undefined labyrinth trophoblast 
6 cell; PE, parietal endoderm; P-TGCs, parietal TGC; SMA cell, smooth muscle actin cell; 
7 SpT, spongiotrophoblast cells; SpA-TGC, spiral artery TGC; S-TGC, sinusoidal TGC; 
8 TGC, trophoblast giant cell; TS cell, trophoblast stem cell; YS, yolk sac. 
9
10 References
11 Albano RM, Arkell R, Beddington RS & Smith JC 1994 Expression of inhibin subunits 
12 and follistatin during postimplantation mouse development: decidual expression of 
13 activin and expression of follistatin in primitive streak, somites and hindbrain. 
14 Development 120 803-813.
15 Ashley RL, Henkes LE, Bouma GJ, Pru JK & Hansen TR 2010 Deletion of the Isg15 
16 gene results in up-regulation of decidual cell survival genes and down-regulation of 
17 adhesion genes: implication for regulation by IL-1beta. Endocrinology 151 4527-
18 4536.
19 Bell SE, Sanchez MJ, Spasic-Boskovic O, Santalucia T, Gambardella L, Burton GJ, 
20 Murphy JJ, Norton JD, Clark AR & Turner M 2006 The RNA binding protein 
21 Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates 
22 VEGF expression. Dev Dyn 235 3144-3155.
23 Geva E, Ginzinger DG, Moore DH, 2nd, Ursell PC & Jaffe RB 2005 In utero 
24 angiopoietin-2 gene delivery remodels placental blood vessel phenotype: a murine 
25 model for studying placental angiogenesis. Mol Hum Reprod 11 253-260.
26 Han X, Wang R, Zhou Y, Fei L, Sun H, Lai S, Saadatpour A, Zhou Z, Chen H, Ye F, et 
27 al. 2018 Mapping the Mouse Cell Atlas by Microwell-Seq. Cell 172 1091-1107 
28 e1017.
Page 50 of 53Accepted Manuscript published as REP-19-0293.R2. Accepted for publication: 18-Nov-2019
Copyright © 2019 Society of Reproduction and FertilityDownloaded from Bioscientifica.com at 11/29/2019 03:31:29PM
via University of Cambridge
29 Li P, Peng H, Lu WH, Shuai HL, Zha QB, Yeung CK, Li H, Wang LJ, Ho Lee KK, Zhu 
30 WJ, et al. 2015 Role of Slit2/Robo1 in trophoblast invasion and vascular remodeling 
31 during ectopic tubal pregnancy. Placenta 36 1087-1094.
32 Makkar A, Mishima T, Chang G, Scifres C & Sadovsky Y 2014 Fatty acid binding 
33 protein-4 is expressed in the mouse placental labyrinth, yet is dispensable for 
34 placental triglyceride accumulation and fetal growth. Placenta 35 802-807.
35 McConaha ME, Eckstrum K, An J, Steinle JJ & Bany BM 2011 Microarray assessment 
36 of the influence of the conceptus on gene expression in the mouse uterus during 
37 decidualization. Reproduction 141 511-527.
38 Nishiyama M, Nita A, Yumimoto K & Nakayama KI 2015 FBXL12-Mediated Degradation 
39 of ALDH3 is Essential for Trophoblast Differentiation During Placental 
40 Development. Stem Cells 33 3327-3340.
41 Rakoczy J, Lee S, Weerasekera SJ, Simmons DG & Dawson PA 2015 Placental and 
42 fetal cysteine dioxygenase gene expression in mouse gestation. Placenta 36 956-
43 959.
44 Simmons DG, Rawn S, Davies A, Hughes M & Cross JC 2008 Spatial and temporal 
45 expression of the 23 murine Prolactin/Placental Lactogen-related genes is not 
46 associated with their position in the locus. BMC Genomics 9 352.
47 Stumpo DJ, Byrd NA, Phillips RS, Ghosh S, Maronpot RR, Castranio T, Meyers EN, 
48 Mishina Y & Blackshear PJ 2004 Chorioallantoic fusion defects and embryonic 
49 lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc 
50 finger protein of the Tristetraprolin family. Mol Cell Biol 24 6445-6455.
51 Yang H, Ahn C & Jeung EB 2015 Differential expression of calcium transport genes 
52 caused by COMT inhibition in the duodenum, kidney and placenta of pregnant 
53 mice. Mol Cell Endocrinol 401 45-55.
54
Page 51 of 53 Accepted Manuscript published as REP-19-0293.R2. Accepted for publication: 18-Nov-2019
Copyright © 2019 Society of Reproduction and FertilityDownloaded from Bioscientifica.com at 11/29/2019 03:31:29PM
via University of Cambridge
1 Supplementary Table 4. Intersection of enhancer-promoter units (EPUs) and DEGs in 
2 mouse placentas of transferred conceptuses at E10.5.
EPU chr Gene name ensembl_gene_id FC padj
EPU_1 Gm15850 ENSMUSG00000086264 2.06 0.044692317chr1
Gm26781 ENSMUSG00000097433 2.36 0.001894297
4930523C07Rik ENSMUSG00000090394 2.59 6.00E-19EPU_2 chr1
Tnn ENSMUSG00000026725 4.15 1.40E-07
Itln1 ENSMUSG00000038209 246.27 9.25E-12EPU_3 chr1
Ly9 ENSMUSG00000004707 2.04 0.004582751
Ifi213 ENSMUSG00000073491 2.70 6.65E-06
Ifi208 ENSMUSG00000066677 3.95 3.73E-05
Mndal ENSMUSG00000090272 2.96 3.43E-33
Ifi202b ENSMUSG00000026535 40.50 4.86E-48
EPU_4 chr1
Ifi205 ENSMUSG00000054203 2.15 0.009521903
AI847159 ENSMUSG00000084826 3.05 1.94E-11EPU_5 chr2
Gm14029 ENSMUSG00000086652 2.15 1.11E-16
Sprr2f ENSMUSG00000050635 4.09 2.24E-73EPU_6 chr3
Sprr2g ENSMUSG00000046203 5.19 8.43E-08
Selenbp2 ENSMUSG00000068877 11.23 3.30E-08EPU_7 chr3
Gm15264 ENSMUSG00000081355 11.02 6.06E-22
Fam46c ENSMUSG00000044468 3.04 2.95E-246EPU_8 chr3
Gm12474 ENSMUSG00000053957 2.44 1.33E-05
Edn2 ENSMUSG00000028635 7.15 4.73E-06EPU_9 chr4
Foxo6 ENSMUSG00000052135 5.33 0.040654175
Clcnkb ENSMUSG00000006216 75.48 0.019122743EPU_10 chr4
Hspb7 ENSMUSG00000006221 16.67 4.32E-48
Chd5 ENSMUSG00000005045 2.63 7.50E-42EPU_11 chr4
Kcnab2 ENSMUSG00000028931 2.02 1.06E-08
Trbc1 ENSMUSG00000076490 2.00 8.37E-49EPU_12 chr6
Trpv6 ENSMUSG00000029868 3.68 3.16E-13
Aicda ENSMUSG00000040627 6.72 1.90E-08EPU_13 chr6
Apobec1 ENSMUSG00000040613 2.58 2.92E-10
Klrb1c ENSMUSG00000030325 9.71 5.19E-16EPU_14 chr6
Klrb1b ENSMUSG00000079298 3.27 6.46E-17
Clec2i ENSMUSG00000030365 3.02 1.62E-48EPU_14 chr6
Klre1 ENSMUSG00000050241 2.63 0.017626571
Klrd1 ENSMUSG00000030165 2.71 0.001680801
Klra4 ENSMUSG00000079852 8.83 2.84E-05
Klra8 ENSMUSG00000089727 6.82 1.60E-46
Klra14-ps ENSMUSG00000072721 8.07 0.001104723
Klra7 ENSMUSG00000067599 5.60 0.023579355
Klra13-ps ENSMUSG00000030178 2.87 2.64E-05
EPU_15 chr6
Styk1 ENSMUSG00000032899 2.19 0.000660299
Klk9 ENSMUSG00000047884 4.07 0.022546162EPU_16 chr7
Klk8 ENSMUSG00000064023 3.25 0.047080871
Trim5 ENSMUSG00000060441 2.01 0.000295991
Trim12a ENSMUSG00000066258 2.14 6.65E-05
EPU_17 chr7
Trim30d ENSMUSG00000057596 2.04 7.85E-07
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Bco1 ENSMUSG00000031845 2.55 9.37E-07EPU_18 chr8
Gm20694 ENSMUSG00000093446 3.07 1.54E-21
Gm7257 ENSMUSG00000023093 7.67 0.01393948EPU_19 chr9
Gm9513 ENSMUSG00000090710 7.90 5.04E-08
Jhy ENSMUSG00000032023 3.04 0.004658411EPU_20 chr9
Crtam ENSMUSG00000032021 2.83 1.88E-06
Prl8a1 ENSMUSG00000019756 2.90 4.23E-11EPU_21 chr13
Prl7a1 ENSMUSG00000006488 2.85 0.008311304
Rnase4 ENSMUSG00000021876 4.43 1.62E-05EPU_22 chr14
Ang ENSMUSG00000072115 2.21 7.06E-09
Gzmn ENSMUSG00000015443 2.23 0.00522498EPU_23 chr14
Gzmb ENSMUSG00000015437 2.18 0.006425581
Adamdec1 ENSMUSG00000022057 1194.78 4.01E-08EPU_24 chr14
Adam28 ENSMUSG00000014725 57.59 3.56E-09
Tff1 ENSMUSG00000024032 2.75 1.50E-24EPU_25 chr17
Ubash3a ENSMUSG00000042345 2.01 0.022452667
Lst1 ENSMUSG00000073412 2.09 4.01E-05
H2-Q1 ENSMUSG00000079507 16.56 2.96E-08
H2-Q2 ENSMUSG00000091705 29.40 0.000132378
H2-Q5 ENSMUSG00000055413 2.06 4.96E-13
H2-Q10 ENSMUSG00000067235 13.01 0.001118777
EPU_26 chr17
Cdsn ENSMUSG00000039518 3.06 1.38E-25
H2-T24 ENSMUSG00000053835 2.69 0.014453217
Gm11127 ENSMUSG00000079492 164.59 4.34E-10
Gm8810 ENSMUSG00000091373 537.65 0.000572567
Gm10499 ENSMUSG00000073403 573.81 2.17E-14
EPU_27 chr17
Gm8909 ENSMUSG00000073402 70.98 0.000951945
Pcdhga1 ENSMUSG00000103144 2.52 1.05E-05EPU_28 chr18
Pcdhgb7 ENSMUSG00000104063 2.29 2.60E-06
Ctsf ENSMUSG00000083282 2.02 6.71E-05EPU_29 chr19
Actn3 ENSMUSG00000006457 8.40 0.028619096
Ms4a4b ENSMUSG00000056290 3.71 0.025157384EPU_30 chr19
Ms4a6c ENSMUSG00000079419 2.09 0.018793207
Sfrp5 ENSMUSG00000018822 4.15 0.002602491EPU_31 chr19
Golga7b ENSMUSG00000042532 2.41 0.035772232
Gm5127 ENSMUSG00000073010 4.69 0.026925397
P2ry10 ENSMUSG00000050921 3.55 1.09E-05
EPU_32 chrX
A630033H20Rik ENSMUSG00000054293 2.11 0.046901925
Mid1 ENSMUSG00000035299 2.27 1.41E-05
G530011O06Rik ENSMUSG00000072844 14.49 1.93E-10
EPU_33 chrX
Gm15726 ENSMUSG00000087263 4.86 0.002939615
3
4 See also Figure 5. Chr, chromosome; EPU, enhancer-promoter unit; FC, fold change.
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